| Dr Jennifer Greenhow Keller, MD | |
|
8 Prospect St, Nashua Anesthesia Partners, Snhmc, Nashua, NH 03060-1000 | |
| (603) 577-2000 | |
| Not Available |
| Full Name | Dr Jennifer Greenhow Keller |
|---|---|
| Gender | Female |
| Speciality | Anesthesiology |
| Experience | 23 Years |
| Location | 8 Prospect St, Nashua, New Hampshire |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1336163492 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 0420011431 (Vermont) | Secondary |
| 207L00000X | Anesthesiology | 13106 (New Hampshire) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Gifford Medical Center | Randolph, VT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Medstream Anesthesia Pllc | 7416198049 | 566 |
News Archive
Researchers at the University of North Carolina School of Medicine announced the publication of results from a multi-site phase 2 clinical trial with brexanolone, an investigational medication, in the treatment of severe postpartum depression.
Seeking to advance minimally invasive medical treatments, researchers have proposed using tiny robots, driven by magnetic potential energy from magnetic resonance imaging (MRI) scanners.
Neuralstem, Inc., a biopharmaceutical company using neural stem cell technology to develop small molecule and cell therapy treatments for central nervous system diseases, announced that the poster "Human Neural Stem Cells Expressing IGF-1: A Novel Cellular Therapy for Alzheimer's Disease" was presented yesterday at the International Society for Stem Cell Research (ISSCR) Annual Meeting in Stockholm, Sweden.
With 125 million Americans challenged by at least one chronic illness and 22% of that number facing life with two or more chronic illnesses, early, smart estate and financial planning can make the difference between maximizing control over your life or falling victim to its exigencies.
› Verified 7 days ago
| Entity Name | Gifford Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942329446 PECOS PAC ID: 4880683663 Enrollment ID: O20040507000460 |
News Archive
Researchers at the University of North Carolina School of Medicine announced the publication of results from a multi-site phase 2 clinical trial with brexanolone, an investigational medication, in the treatment of severe postpartum depression.
Seeking to advance minimally invasive medical treatments, researchers have proposed using tiny robots, driven by magnetic potential energy from magnetic resonance imaging (MRI) scanners.
Neuralstem, Inc., a biopharmaceutical company using neural stem cell technology to develop small molecule and cell therapy treatments for central nervous system diseases, announced that the poster "Human Neural Stem Cells Expressing IGF-1: A Novel Cellular Therapy for Alzheimer's Disease" was presented yesterday at the International Society for Stem Cell Research (ISSCR) Annual Meeting in Stockholm, Sweden.
With 125 million Americans challenged by at least one chronic illness and 22% of that number facing life with two or more chronic illnesses, early, smart estate and financial planning can make the difference between maximizing control over your life or falling victim to its exigencies.
› Verified 7 days ago
| Entity Name | Medstream Anesthesia Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649616160 PECOS PAC ID: 7416198049 Enrollment ID: O20201223000259 |
News Archive
Researchers at the University of North Carolina School of Medicine announced the publication of results from a multi-site phase 2 clinical trial with brexanolone, an investigational medication, in the treatment of severe postpartum depression.
Seeking to advance minimally invasive medical treatments, researchers have proposed using tiny robots, driven by magnetic potential energy from magnetic resonance imaging (MRI) scanners.
Neuralstem, Inc., a biopharmaceutical company using neural stem cell technology to develop small molecule and cell therapy treatments for central nervous system diseases, announced that the poster "Human Neural Stem Cells Expressing IGF-1: A Novel Cellular Therapy for Alzheimer's Disease" was presented yesterday at the International Society for Stem Cell Research (ISSCR) Annual Meeting in Stockholm, Sweden.
With 125 million Americans challenged by at least one chronic illness and 22% of that number facing life with two or more chronic illnesses, early, smart estate and financial planning can make the difference between maximizing control over your life or falling victim to its exigencies.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jennifer Greenhow Keller, MD Po Box 1051, 831 Covered Bridge Lane, Grantham, NH 03753-1051 Ph: (603) 381-5712 | Dr Jennifer Greenhow Keller, MD 8 Prospect St, Nashua Anesthesia Partners, Snhmc, Nashua, NH 03060-1000 Ph: (603) 577-2000 |
News Archive
Researchers at the University of North Carolina School of Medicine announced the publication of results from a multi-site phase 2 clinical trial with brexanolone, an investigational medication, in the treatment of severe postpartum depression.
Seeking to advance minimally invasive medical treatments, researchers have proposed using tiny robots, driven by magnetic potential energy from magnetic resonance imaging (MRI) scanners.
Neuralstem, Inc., a biopharmaceutical company using neural stem cell technology to develop small molecule and cell therapy treatments for central nervous system diseases, announced that the poster "Human Neural Stem Cells Expressing IGF-1: A Novel Cellular Therapy for Alzheimer's Disease" was presented yesterday at the International Society for Stem Cell Research (ISSCR) Annual Meeting in Stockholm, Sweden.
With 125 million Americans challenged by at least one chronic illness and 22% of that number facing life with two or more chronic illnesses, early, smart estate and financial planning can make the difference between maximizing control over your life or falling victim to its exigencies.
› Verified 7 days ago
Praveen K Suchdev, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 280 Main St, Ste 330, Nashua, NH 03060 Phone: 603-577-3003 Fax: 603-577-3331 | |
Dr. Michael James Pedro, M.D. Anesthesiology Medicare: Medicare Enrolled Practice Location: 8 Prospect St, Nashua, NH 03060 Phone: 603-577-2000 | |
Michael K. Magee, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 2300 Southwood Dr, Nashua, NH 03063 Phone: 603-577-4170 | |
Dr. Gabriela Andrade Calhoun, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 8 Prospect St, Nashua, NH 03060 Phone: 603-281-6503 | |
Howard E. Krasner, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 8 Prospect St, Anesthesia Department, Nashua, NH 03060 Phone: 603-889-2624 | |
Gary B. Friedman, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 8 Prospect St, Anesthesia Department, Nashua, NH 03060 Phone: 603-889-2624 |